Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Advanced Oxygen Technologies (AOXY) Cash & Equivalents (2016 - 2025)

Advanced Oxygen Technologies (AOXY) has disclosed Cash & Equivalents for 17 consecutive years, with $33958.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 47.4% year-over-year to $33958.0, compared with a TTM value of $33958.0 through Dec 2025, down 47.4%, and an annual FY2025 reading of $57225.0, down 39.43% over the prior year.
  • Cash & Equivalents was $33958.0 for Q4 2025 at Advanced Oxygen Technologies, down from $45546.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $108015.0 in Q4 2023 and bottomed at $33958.0 in Q4 2025.
  • Average Cash & Equivalents over 5 years is $78981.6, with a median of $91089.5 recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 110.85% in 2022, then tumbled 48.22% in 2025.
  • Year by year, Cash & Equivalents stood at $99177.0 in 2021, then grew by 2.7% to $101854.0 in 2022, then increased by 6.05% to $108015.0 in 2023, then tumbled by 40.23% to $64563.0 in 2024, then plummeted by 47.4% to $33958.0 in 2025.
  • Business Quant data shows Cash & Equivalents for AOXY at $33958.0 in Q4 2025, $45546.0 in Q3 2025, and $57225.0 in Q2 2025.